Johnson & Johnson's $6.5 billion settlement proposal -- to be ... In 2016, J&J was were ordered to pay $55 million to a 62-year-old South Dakota woman who said she developed ovarian cancer after ...
J&J will buy Momenta Pharmaceuticals for roughly $6.5 billion in cash, paving the way for its Janssen unit to expand its efforts into autoimmune disease treatments. J&J will pay $52.50 for each ...
Five plaintiffs sued Johnson & Johnson on Wednesday, accusing the company of fraud through its use of a shell company's ...
Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ... The pharmaceutical giant is set to pay ...
that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered to pay $6.475 billion in response to thousands of lawsuits that have alleged ...
"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato. Johnson & Johnson said it will pay $380 ...
Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press Even ...
The fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...
J&J faces about 40,000 lawsuits related to its baby powder and has already been forced to pay billions in damages. News that a federal appellate court ruled that Johnson & Johnson can't use a ...
Johnson Brothers Liquor Co. distributes wine and spirits. Its services include distribution, sales consulting and printing services. The company was founded by Lynn W. Johnson in 1953 and is ...
Titans WR Andre Johnson is retiring. The 35-year-old made his legacy with the Texans, where he is by far the franchise leader in receiving yards and receptions.